Cytarabine and Ureaplasma infection (expanded source)


Ureaplasma infection is reported only by a few people who take Cytarabine. We study 24,079 people who have side effects while taking Cytarabine from FDA. Among them, 3 have Ureaplasma infection. Find out below who they are, when they have Ureaplasma infection and more.



On Jul, 15, 2018

24,079 people reported to have side effects when taking Cytarabine.
Among them, 3 people (0.01%) have Ureaplasma infection


Number of reports submitted per year:

Could Cytarabine cause Ureaplasma infection?

Gender of people who have Ureaplasma infection when taking Cytarabine *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Ureaplasma infection when taking Cytarabine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 100 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  1. Diffuse Large B-Cell Lymphoma Stage Ii (cancer of b cells, a type of white blood cell-stage ii): 1 person, 33.33%
  2. Bone Marrow Conditioning Regimen: 1 person, 33.33%

Top co-used drugs for these people *:

  1. Methylprednisolone: 3 people, 100.00%
  2. Methotrexate: 3 people, 100.00%
  3. Fludarabine Phosphate: 3 people, 100.00%
  4. Etoposide: 3 people, 100.00%
  5. Cisplatin: 3 people, 100.00%

Top other side effects for these people *:

  1. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 100.00%
  2. Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 3 people, 100.00%
  3. Renal Failure Acute (rapid kidney dysfunction): 2 people, 66.67%
  4. Cytomegalovirus Infection: 2 people, 66.67%
  5. Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Experience matters! A new approach to health care:

What's next: manage your medications



Related studies

Cytarabine

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. (latest outcomes from Cytarabine 24,099 users)

Ureaplasma infection

Ureaplasma infection has been reported by people with hiv infection, immunodeficiency disorders, crohn's disease, staphylococcal infection, lung transplant (latest reports from 65 Ureaplasma infection patients).


Drugs that are associated with Ureaplasma infection
Ureaplasma infection (41 drugs)
Could your condition cause Ureaplasma infection
Ureaplasma infection (34 conditions)
Cytarabine side effects
Browse all side effects of Cytarabine
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Cytarabine and have Ureaplasma infection


You are not alone. Join our personalized support groups:


You may be interested in these posts

More posts for: Cytarabine, Ureaplasma infection

Recent updates

General studies
Active Support Groups
Latest posts

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.